Related Experiment Videos
Affinity assays using fluorescence anisotropy with capillary electrophoresis separation
Rebecca J Whelan1, Roger K Sunahara, Richard R Neubig
1Department of Chemistry and Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Analytical Chemistry
|December 15, 2004
Summary
A new Fluorescence Anisotropy with Capillary Electrophoresis (FACE) method detects molecular binding. This technique separates and confirms interactions, offering a sensitive assay for identifying binding partners in complex samples.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Biophysics
Background:
- Affinity interactions are crucial for biological processes.
- Accurate detection and quantification of these interactions are essential for drug discovery and diagnostics.
- Existing methods may lack the sensitivity or specificity required for complex biological samples.
Purpose of the Study:
- To develop a novel method combining fluorescence anisotropy and capillary electrophoresis (FACE) for detecting molecular binding.
- To provide a technique that offers both separation and confirmation of binding events.
- To establish a sensitive and quantifiable assay for identifying binding partners.
Main Methods:
- Developed a Fluorescence Anisotropy with Capillary Electrophoresis (FACE) assay.
- Utilized a fluorescent probe with low fluorescence anisotropy.
- Detected binding through a positive anisotropy shift during capillary electrophoresis.
- Employed calculations combining the Perrin equation and dissociation constant to predict assay performance.
Main Results:
- Experimental results aligned with theoretical predictions regarding probe and protein concentrations.
- Demonstrated successful detection of G proteins using BODIPY FL GTPgammaS as the fluorescent probe.
- Achieved a limit of detection of 3 nM for G(alphai1) with 250 nM probe concentration.
Conclusions:
- The FACE assay effectively detects and quantifies molecular binding interactions.
- The method offers high sensitivity, with a low limit of detection for specific binding partners.
- FACE has potential applications in screening complex samples for compounds with affinity for target molecules.